Valganciclovir prophylaxis extension from 3 to 6 months in high-risk pancreas-transplant recipients does not impact incidence of cytomegalovirus infection at 12 months

Margaret R. Jorgenson, Nicholas Marka, Glen E. Leverson, Jeannina A. Smith, Jon S. Odorico

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Valganciclovir prophylaxis extension from 3 to 6 months in high-risk pancreas-transplant recipients does not impact incidence of cytomegalovirus infection at 12 months'. Together they form a unique fingerprint.

Medicine & Life Sciences